These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


598 related items for PubMed ID: 17087625

  • 41. A nonprostanoid EP4 receptor selective prostaglandin E2 agonist restores bone mass and strength in aged, ovariectomized rats.
    Ke HZ, Crawford DT, Qi H, Simmons HA, Owen TA, Paralkar VM, Li M, Lu B, Grasser WA, Cameron KO, Lefker BA, DaSilva-Jardine P, Scott DO, Zhang Q, Tian XY, Jee WS, Brown TA, Thompson DD.
    J Bone Miner Res; 2006 Apr; 21(4):565-75. PubMed ID: 16598377
    [Abstract] [Full Text] [Related]

  • 42. Human parathyroid hormone-(1-34) prevents bone loss and augments bone formation in sexually mature ovariectomized rats.
    Liu CC, Kalu DN.
    J Bone Miner Res; 1990 Sep; 5(9):973-82. PubMed ID: 2281827
    [Abstract] [Full Text] [Related]

  • 43. Long-term zoledronic acid treatment increases bone structure and mechanical strength of long bones of ovariectomized adult rats.
    Hornby SB, Evans GP, Hornby SL, Pataki A, Glatt M, Green JR.
    Calcif Tissue Int; 2003 Apr; 72(4):519-27. PubMed ID: 12574877
    [Abstract] [Full Text] [Related]

  • 44. The anabolic action of intermittent PTH in combination with cathepsin K inhibitor or alendronate differs depending on the remodeling status in bone in ovariectomized mice.
    Yamane H, Sakai A, Mori T, Tanaka S, Moridera K, Nakamura T.
    Bone; 2009 Jun; 44(6):1055-62. PubMed ID: 19303837
    [Abstract] [Full Text] [Related]

  • 45. Long-term changes in bone mineral and biomechanical properties of vertebrae and femur in aging, dietary calcium restricted, and/or estrogen-deprived/-replaced rats.
    Jiang Y, Zhao J, Genant HK, Dequeker J, Geusens P.
    J Bone Miner Res; 1997 May; 12(5):820-31. PubMed ID: 9144349
    [Abstract] [Full Text] [Related]

  • 46. A comparative study of the bone metabolic response to dried plum supplementation and PTH treatment in adult, osteopenic ovariectomized rat.
    Smith BJ, Bu SY, Wang Y, Rendina E, Lim YF, Marlow D, Clarke SL, Cullen DM, Lucas EA.
    Bone; 2014 Jan; 58():151-9. PubMed ID: 24125756
    [Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48. Biosynthetic human parathyroid hormone (1-34) effects on bone quality in aged ovariectomized rats.
    Sato M, Zeng GQ, Turner CH.
    Endocrinology; 1997 Oct; 138(10):4330-7. PubMed ID: 9322947
    [Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51. Unmasking the osteoinductive effects of a G-protein-coupled receptor (GPCR) kinase (GRK) inhibitor by treatment with PTH(1-34).
    Wang L, Quarles LD, Spurney RF.
    J Bone Miner Res; 2004 Oct; 19(10):1661-70. PubMed ID: 15355561
    [Abstract] [Full Text] [Related]

  • 52. RANKL inhibition with osteoprotegerin increases bone strength by improving cortical and trabecular bone architecture in ovariectomized rats.
    Ominsky MS, Li X, Asuncion FJ, Barrero M, Warmington KS, Dwyer D, Stolina M, Geng Z, Grisanti M, Tan HL, Corbin T, McCabe J, Simonet WS, Ke HZ, Kostenuik PJ.
    J Bone Miner Res; 2008 May; 23(5):672-82. PubMed ID: 18433301
    [Abstract] [Full Text] [Related]

  • 53. Long-term treatment of indomethacin reduces vertebral bone mass and strength in ovariectomized rats.
    Saino H, Matsuyama T, Takada J, Kaku T, Ishii S.
    J Bone Miner Res; 1997 Nov; 12(11):1844-50. PubMed ID: 9383689
    [Abstract] [Full Text] [Related]

  • 54. Denosumab, a fully human RANKL antibody, reduced bone turnover markers and increased trabecular and cortical bone mass, density, and strength in ovariectomized cynomolgus monkeys.
    Ominsky MS, Stouch B, Schroeder J, Pyrah I, Stolina M, Smith SY, Kostenuik PJ.
    Bone; 2011 Aug; 49(2):162-73. PubMed ID: 21497676
    [Abstract] [Full Text] [Related]

  • 55. Effect of 16 months of treatment with tibolone on bone mass, turnover, and biomechanical quality in mature ovariectomized rats.
    Ederveen AG, Spanjers CP, Quaijtaal JH, Kloosterboer HJ.
    J Bone Miner Res; 2001 Sep; 16(9):1674-81. PubMed ID: 11547837
    [Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58. Tower climbing exercise started 3 months after ovariectomy recovers bone strength of the femur and lumbar vertebrae in aged osteopenic rats.
    Notomi T, Okimoto N, Okazaki Y, Nakamura T, Suzuki M.
    J Bone Miner Res; 2003 Jan; 18(1):140-9. PubMed ID: 12510816
    [Abstract] [Full Text] [Related]

  • 59. An intact N terminus is required for the anabolic action of parathyroid hormone on adult female rats.
    Armamento-Villareal R, Ziambaras K, Abbasi-Jarhomi SH, Dimarogonas A, Halstead L, Fausto A, Avioli LV, Civitelli R.
    J Bone Miner Res; 1997 Mar; 12(3):384-92. PubMed ID: 9076581
    [Abstract] [Full Text] [Related]

  • 60. The addition of a raloxifene analog (LY117018) allows for reduced PTH(1-34) dosing during reversal of osteopenia in ovariectomized rats.
    Hodsman AB, Drost D, Fraher LJ, Holdsworth D, Thornton M, Hock J, Bryant H, Watson PH.
    J Bone Miner Res; 1999 May; 14(5):675-9. PubMed ID: 10320515
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 30.